🌟 Ready to lead the change in transforming prostate cancer care? 🚀 Gain crucial leadership and change management skills on our Clinical Champions Programme! 🌐✨ Apply now

In light of the growing body of evidence around screening the APPG on #ProstateCancer we were delighted to hear from experts from within the European Praise-U consortium earlier this year about the approaches and methods being undertaken in other countries. Read the report here: buff.ly/uqqAMNU

The December edition of Research News is here! Find out about: 🔬 An exciting research project. 💻 A new webinar series. 🩺 UK Prostate Cancer Clinical Research Strategy Group. 💬 Discussion session topic at From Ideas to Innovation. 📚 Read it here: buff.ly/kXTXjdx

Excited to share our new study from @asharpmedonc.bsky.social lab at @icr.ac.uk 🔬✨ We identify therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer. So happy to have to co-led this work with my colleagues and friends #DanWestaby & @inesfigueiredo.bsky.social 🔗 bit.ly/4oHSvNx

Could targeting MCL1 & BCLXL be effective in advanced #ProstateCancer? Research in @cp-iscience.bsky.social led by Dr Westaby, @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social & Prof de Bono, supported by our Movember London Centre of Excellence. Grab a ☕ & read: doi.org/10.1016/j.is...

Upcoming webinar: Augmented SBRT & precision in prostate cancer treatment. Hear about current approaches, practical considerations developments within this area. 📅 Jan 28 ⏰ 3:00–4:30 CEST 📍 Zoom Register: bit.ly/492iMjT

Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience. 🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.

🖥️ Don't miss the next webinar from the European Prostate Cancer Alliance on 'Tumour heterogeneity and molecular imaging', featuring Prostate Cancer UK funded researchers Professor Hing Leung and Professor Craig Robson. 📆 15th December ⏰ 15:00 - 17:15 🔗 t.co/ejVkwgiij9

Dr Joaquin Mateo was a research fellow @icr.ac.uk interested in making personalised #ProstateCancer treatments. In 2014, we funded him to see if men with specific DNA mutations responded favourably to a drug called olaparib. 📙 Read more: prostatecanceruk.org/research/res...

Could machine learning be a future tool to predict protein-protein interactions in #ProstateCancer? A team including Prostate Cancer UK funded Dr Ke Yuan @uofgcancersciences.bsky.social take protein language models a step forward in @natcomms.nature.com. Grab a ☕ and read: doi.org/10.1038/s414...

If you’re a Black healthcare professional, we want to help you drive change in prostate cancer care. Our Clinical Champions Programme will support you to become a transformative leader and make a lasting impact. Apply now 👉

🗣️ YOUR FEEDBACK MATTERS Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations. Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH

Screening takes time but early diagnosis can’t wait. Keep supporting men at risk and stay informed with our latest guidance, education and clinical resources. Sign up to our health professional e-newsletter ➡️ bit.ly/2VktI7b

Ready to lead impactful change? Apply now to be a part of our award-winning 18-month flagship programme. 🌟Apply now: bit.ly/46I5Fn9

📣 We’re looking forward to the discussion session at From Ideas to Innovation, which will explore Equity in Research Career Progression. 🙏We’re grateful to our research community for sharing their insights and experiences. ⬇️ Check out the full agenda. prostatecanceruk.org/research/for...

🥼 Meet Prof Hashim Ahmed and Prof Mark Emberton, researchers and clinicians dedicated to improving the way we diagnose men with prostate cancer. Find out more ➡️ bit.ly/3xSHfYS

🥼 Meet Dr Bunmi Olajide, a GP dedicated to improving cancer care and raising awareness of Black men’s higher risk of prostate cancer. Learn more ➡️ bit.ly/4ip3ysp

🗣️ YOUR FEEDBACK MATTERS Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations. Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH

Could dose–response model parameters influence identification of bladder regions vulnerable to radiotherapy-induced toxicity? A team led by Dr Tanuj Puri, Prof Marcel van Herk & Dr Alan McWilliam @manchester.ac.uk share new findings in Physica Medica. Grab a ☕ & read: doi.org/10.1016/j.ej...

While the NSC has recommended screening only for men with BRCA gene variations, this isn’t the end of the story. Our ongoing research, including TRANSFORM, will provide the evidence needed to expand screening safely in the future. Find out more ➡️ bit.ly/3xSHfYS

🗣️ YOUR FEEDBACK MATTERS Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations. Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH

Friday’s NSC recommendation is a step toward targeted prostate cancer screening for men with BRCA gene variations. However, many men at higher risk are being missed. Read more about the recent announcement here➡️ bit.ly/4ip3ysp

Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience. 🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.

Thank you to all the researchers, clinicians and health professionals who continue to drive progress in early prostate cancer diagnosis 🩵 Your work is helping shape the evidence and care that will save more men’s lives. Read more about it here👉 buff.ly/OojAs47

🚨 BREAKING NEWS The UK NSC has announced support for targeted prostate cancer screening for men with BRCA gene variations. A step forward in earlier detection for men at highest risk. Read our co-signed statement here ➡️ buff.ly/nXIirI0

The November edition of Research News is here! Discover more about: 💙 TRANSFORM - Screening Trial Open! 🧑 UK Prostate Cancer Clinical Research Strategy Group 🤝 An exciting upcoming meeting. 💰 Funding opportunities. 📖 Read it here: buff.ly/WLlHpLg

How does IGF-1 contribute to #ProstateCancer immune evasion? In dedication to the late Professor Valentine Macaulay, a team including Professor Ian Mills from @ndsurgicalsci.bsky.social @ox.ac.uk detail novel findings in Scientific Reports. Grab a ☕ and read: doi.org/10.1038/s415...

Are you someone living with or beyond cancer? Researchers at the University of Aberdeen are inviting you to participate in a questionnaire about taking care of your health. More info and questionnaire here: iahs.qualtrics.com/jfe/form/SV_...

👩‍⚕️ Are you a healthcare professional from Scotland, Wales, or Northern Ireland? Apply to our Clinical Champions Programme to drive real improvements in prostate cancer care with expert support. Find out more 👉 bit.ly/46I5Fn9

Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience. 🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.

Could zoledronic acid lower fracture risk in advanced hormone-sensitive #ProstateCancer? @asachdeva.bsky.social & team @manchester.ac.uk, funded by our Movember FASTMAN Centre of Excellence, share their analysis in Annals of Oncology. Grab a ☕ & read: doi.org/10.1016/j.an...

Are you a healthcare professional who'd like to understand the latest evidence on the role of genomics in risk prediction, targeted screening and personalised treatment? 👇Register now to join us at @roysocmed.bsky.social and be part of shaping genomics-informed #ProstateCancer care.

Could CAR-T cells carrying collagen targeted IL-12 be a safe therapy for #ProstateCancer? A team including Prostate Cancer UK fellow @Ko1ssk.bsky.social & Jun Ishihara @imperialcollegeldn.bsky.social share new results in @natbiomedeng.nature.com. Grab a ☕ and read: doi.org/10.1038/s415...

📢Careers in Research Webinar📢 🤔Got a great idea, but not sure how to turn it into a clinical trial? 📉Curious about careers in trials – stats, methods, data? Register to explore how partnering with a CTSU can support researchers at every stage 👇 events.teams.microsoft.com/event/2b9a0b...

Calling all Clinician and AHPs 👨‍⚕️ 👩‍⚕️ Apply for our free 18-month flagship Clinical Champions Programme. Become a leader in transforming care and support for men impacted by prostate cancer. Apply today 👉 bit.ly/46I5Fn9

Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience. 🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.

Could genetic information help personalise radiotherapy to reduce rectal toxicity? A team led by Dr Alan McWilliam and Artemis Bouzaki at @manchester.ac.uk report exciting new findings in Clinical Cancer Research. Grab a ☕ and read: doi.org/10.1158/1078...

🧵[1/6] 📣 Big news for clinical prostate cancer researchers! The NCRI Prostate Group has re-established as UK Prostate Cancer Clinical Research Strategy Group (CRSG) - a national hub for collaboration & innovation in prostate cancer research. Learn more 👇 prostatecanceruk.org/research/for...

🎵 Movin’ for Men’s Health! One of our brilliant researchers, Prof. Charlotte Bevan, is hosting a Soul Nite to raise funds for @prostateuk.bsky.social and Movember. 📅 When: 8pm, 8th November 📍 Where: The Camden Club, London Find out more and register ⤵️ buff.ly/vidaQg8

Last month, we launched our new One-to-One support service for Black men, which operates alongside our existing peer support service. Please signpost Black men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer. 💙

🗣️ Just 1 week left to share your views on the 10-year NHS England workforce plan! Share your views on: 🔜Future NHS workforce models 📋How to support delivery of the 3-shifts 🥼How to align staff with the future of the NHS in England 📅Due 7 Nov buff.ly/DuyIVqU

Could radiomic features guide adaptive radiotherapy to minimise rectal toxicity? A brilliant team led by Prof. Bill Nailon, Prof. Duncan McLaren and Dr Zhuolin Yang at @uni-of-edinburgh.bsky.social share interesting new findings in phiRO. Grab a ☕ and read: doi.org/10.1016/j.ph...

📣Each From Ideas to Innovation session will feature a reflection by a Patient Research Partner (PRP) -a man or family member affected by #ProstateCancer. 🙏We’re grateful to our PRPs for sharing their stories & shaping our research. ⬇️ Register to attend. prostatecanceruk.org/research/for...

🗣️ Hear from experts sharing the latest data on the use of genetic information in prostate cancer care at the high-profile conference, Genomics and Prostate Cancer. 📅 Friday 12 December 📍 The Royal Society of Medicine, London ➡️ Secure your place: bit.ly/4pS5cGz

There’s still time to share your thoughts on the 10-year NHS England workforce plan! Share your views on: 🔜Future NHS workforce models 📋How to support delivery of the 3-shifts 🥼How to align staff with the future of the NHS in England 📅Due 7 Nov buff.ly/DuyIVqU

The October edition of Research News is here! Read more about: 🚴 Tour de 4. 🤝 Upcoming meetings and webinars. 🌱 A personal development resource. 🗣️ Speakers at our researcher event, From Ideas to Innovation. 💰 Funding opportunities. 📖 Read it here: prostatecanceruk.org/research/for...

[1/9] 🔎 Let’s take a closer look at the exciting findings from the Prostate Cancer UK-funded study led by @veerukasi.bsky.social, Dr Alex Ng & Dr Aqua Asif at @ucl.ac.uk recently published in @jama.com 🧵.

Can expanding germline testing improve #ProstateCancer risk detection in men of African ancestry? A great team effort led by Prof Vanessa Hayes with Prof Ros Eeles from @icr.ac.uk, and the PPCG, published in @natcomms.nature.com Grab a ☕ and read: doi.org/10.1038/s414...

📢 @cancerresearchuk.org has refreshed their career support for clinical academics, aiming to address some of the specific challenges they face. 💻 Join their webinar on 19 November to learn more and ask your questions. Register using the link below! ⤵️ buff.ly/CZx2ANJ

Congratulations team!! Great to see data from STOPCAP presented on such an international platform!